Eli Lilly and Company is seeking a positive opinion from the EMA regarding the potential indication expansion for its drug, pirtobrutinib.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• EMA →

  Japanese vocalist of the group DUSTCELL

  Nothing else this week.

• European Commission →

  executive branch of the European Union

  • The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
  • The European Commission has initiated economic support measures for Armenia, including funding transfers, trade program development, and import restrictions.Mon 17:26

Related events

• Oncopeptides AB's drug received a positive opinion from the EMA, leading to the European Commission making a final decision for the EU market.Sep 17